发明名称 POXVIRIDAE TREATMENT COMPRISING TAP-1 AND/OR TAP-2 AS A MOLECULAR ADJUVANT
摘要 <p>A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with pox antigen-based vaccine in treatment or prophylaxis especially of smallpox viral infections.</p>
申请公布号 KR20100014290(A) 申请公布日期 2010.02.10
申请号 KR20097013563 申请日期 2006.11.30
申请人 THE UNIVERSITY OF BRITISH COLUMBIA 发明人 JEFFERIES WILFRED ARTHUR;VITALIS TIMOTHY Z.;ZHANG QIAN JIN;ALIMONTI JUDIE BARBARA;CHEN SUSAN SHU PING;BASHA GENC;CHOI KYUNG BOK
分类号 A61K38/17;A61K39/275;A61K48/00;A61P31/20 主分类号 A61K38/17
代理机构 代理人
主权项
地址